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Following the publication of this article, the authors noted that [Fig. 1](#f1-mmr-17-02-3432){ref-type="fig"} appeared incorrectly in the journal. Essentially, the figure was reorganized but only the labels for [Fig. 1B and C](#f1-mmr-17-02-3432){ref-type="fig"} were switched around, with the result that [Fig. 1B and C](#f1-mmr-17-02-3432){ref-type="fig"} were labelled incorrectly in the paper.

The corrected figure is shown below, with the figure parts for [Fig. 1B and C](#f1-mmr-17-02-3432){ref-type="fig"} now labelled correctly. This error was introduced into the figure during the pre-press stages. The editorial office wishes to apologize to the authors for this mistake, and we regret the inconvenience this mistake has caused.

![Exogenous regucalcin suppresses the proliferation of MDA-MB-231 cells *in vitro*. Cells were cultured in the presence or absence of regucalcin (0.1--10 nM) for (A) 1, (B) 2, (C) 3 or (D) 7 days. Following culture, the number of cells were counted. Data are presented as the mean ± standard deviation of 2 replicate wells per data set using different dishes and cell preparations. \*P\<0.001 vs. control (grey bar). One way analysis of variance and the Tukey-Kramer post-test were used.](MMR-17-02-3432-g00){#f1-mmr-17-02-3432}
